Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · IEX Real-Time Price · USD
0.432
-0.018 (-4.09%)
At close: Jul 19, 2024, 4:00 PM
0.410
-0.022 (-5.00%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $10.92 million as of July 22, 2024. Its market cap has decreased by -51.24% in one year.
Market Cap
10.92M
Enterprise Value
-5.47M
1-Year Change
-51.24%
Ranking
Category
Stock Price
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $398.90M to $10.92M, a decrease of -97.26%. That is a compound annual growth rate of -27.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 10.90M | -30.57% |
| Dec 29, 2023 | 15.70M | 16.30% |
| Dec 30, 2022 | 13.50M | -74.67% |
| Dec 31, 2021 | 53.30M | -38.10% |
| Dec 31, 2020 | 86.10M | 2,677.42% |
| Dec 31, 2019 | 3.10M | -74.17% |
| Dec 31, 2018 | 12.00M | -18.92% |
| Dec 29, 2017 | 14.80M | -3.27% |
| Dec 30, 2016 | 15.30M | -35.71% |
| Dec 31, 2015 | 23.80M | -66.67% |
| Dec 31, 2014 | 71.40M | -70.95% |
| Dec 31, 2013 | 245.80M | -38.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 11.62M |
| Cardio Diagnostics Holdings | 11.57M |
| Inhibikase Therapeutics | 11.33M |
| BioRestorative Therapies | 11.31M |
| Dominari Holdings | 11.22M |
| Vaccinex | 11.01M |
| Mustang Bio | 10.95M |
| Senti Biosciences | 10.89M |